It is difficult for the 21st century observer to imagine the shock and revulsion Thomas Eakins provoked with both "The Gross Clinic" in 1876.
By Ike Swetlitz, STAT
The Department of Health and Human Services asserted in a letter to the Drug Enforcement Administration that two chemicals in kratom should be classified as Schedule I substances, meaning that the chemicals have “a high potential for abuse” and that…
By Ricardo Alonso-Zaldivar, Associated Press
The changes are a sign of growing recognition that practical help can have a meaningful impact on patients' well-being and reduce costs for taxpayers.
By Elizabeth Cooney, STAT
A new study examining how long black or white people survive after a heart attack concludes that it’s socioeconomic status, far more than race, that explains who fares better.
If Republicans prevail in just two races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and a pharma CEO.
By Kristen de Groot, Associated Press
For those in the hospital unexpectedly, that process isn't exactly simple.
By Michael Balsamo, Associated Press
But federal officials are concerned that methamphetamine and cocaine are being seen at much higher levels in areas that haven't historically been hotspots for those drugs.
President Trump has announced several proposed changes to how Medicare buys certain expensive prescription drugs, relying in part upon a benchmark price index of other developed countries, who negotiate lower prices. But critics wonder why the U.S. government doesn't do…
The best estimates likely under-represent the true scope and scale of intimate partner violence because victims often are afraid to disclose what has happened to them.
By Linda A. Johnson, Associated PRess
Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.